Spectrum pharma stock.
The biopharmaceutical company earned $137.10 million during the quarter, compared to analyst estimates of $97.66 million. GW Pharmaceuticals had a negative trailing twelve-month return on equity of 7.46% and a negative net margin of 11.05%. The company's revenue for the quarter was up 50.7% on a year-over-year basis.
Spectrum Pharmaceuticals, Inc. 2018 Long-Term Incentive Plan (Full title of the plan) 11500 South Eastern Avenue, Suite 220 . Henderson, Nevada 89052 ... The Registrant previously registered shares of Common Stock for issuance under the 2018 Plan on a Registration Statement on Form S-8, filed with the Securities and Exchange Commission …Company profile page for Spectrum Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information.On this news, Spectrum Pharmaceuticals’ stock price fell 31% to close at $0.43 per share on September 23, 2022, on unusually heavy trading volume.Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 ASRT shares per SPPI Share ($1.14 per share) Plus One CVR for Total Potential Consideration of up to $1.34 per Share Upfront...
The latest closing stock price for Spectrum Pharmaceuticals, Inc. on July 31, 2023 is 1.03. The all-time high Spectrum Pharmaceuticals, Inc. closing stock price was 598.32 on March 07, 2000. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.Looking for an internet plan that fits your needs? Spectrum has a variety of options to choose from, so you’re sure to find one that meets your needs. Spectrum is also known for its high-quality customer service.49.31. Torrent Pharmaceuticals. ₹2,151.25. ( +1.16%) 54.22. Sun Pharmaceutical Share Price - Get Sun Pharmaceutical Ltd LIVE BSE/NSE stock price with Performance, Fundamentals, Market Cap, Share holding, financial report, company profile, annual report, quarterly results, profit and loss.
Cross-Spectrum Anti-Viral Compounds Needed for Seasonal and Pandemic Infections with Sam Lee Cocrystal Pharma on Empowered Patient with Karen Jagoda ...
The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to …Investors have been pretty optimistic on Spectrum Pharmaceuticals too, with the stock up 19% to US$1.30 over the past week. It will be interesting to see if today's upgrade is enough to propel the ...The latest Spectrum Pharmaceuticals stock prices, stock quotes, news, and SPPI history to help you invest and trade smarter. It also withdrew its outlook for the full year of 2023! Assertio (NASDAQ: ASRT) stock is falling hard on Friday after the pharmaceutical company released its second-quarter earnings report ...
{"jsonapi":{"version":"1.0","meta":{"links":{"self":{"href":"http:\/\/jsonapi.org\/format\/1.0\/"}}}},"data":{"type":"node--article","id":"07790c5a-1ff8-42ab-badf ...
107,675. $. 103,338. BOSTON, May 09, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a commercial stage biopharmaceutical company focused on novel and targeted oncology therapies, announced ...
Specialty pharmaceutical company Assertio Holdings Inc announced Tuesday that it finalized an agreement to acquire all outstanding shares of Spectrum Pharmaceuticals Inc in an all-stock and ...Find the latest Ampio Pharmaceuticals, Inc. (AMPE) stock quote, history, news and other vital information to help you with your stock trading and investing.Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates 05/09/23-7:25AM EST Zacks Spectrum Pharmaceuticals (SPPI) Reports Q4 Loss, Tops Revenue EstimatesSpectrum Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of one commercial product and product candidates for the treatment of cancer patients.Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon. Read more to see why SPPI stock is a Sell.Legal Name Spectrum Pharmaceuticals, Inc. Stock Symbol NASDAQ:SPPI. Company Type For Profit. Contact Email [email protected]. Phone Number 9497886706. Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus on oncology.Spectrum Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing targeted oncology therapies. The Company's product portfolio consists of one commercial product and product candidates for the treatment of cancer patients.
Symbol Lookup from Yahoo Finance. Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance. Apr 26, 2023 · According to 4 analyst offering 12-month price targets in the last 3 months, Spectrum Pharma has an average price target of $3.19 with a high of $4.00 and a low of $0.75. On this news, shares of Spectrum common stock declined from a closing price of $1.06 per share on September 19, 2022, to a close at $0.66 per share on September 20, 2022, a decline of $0.40 per ...49.31. Torrent Pharmaceuticals. ₹2,151.25. ( +1.16%) 54.22. Sun Pharmaceutical Share Price - Get Sun Pharmaceutical Ltd LIVE BSE/NSE stock price with Performance, Fundamentals, Market Cap, Share holding, financial report, company profile, annual report, quarterly results, profit and loss.🇺🇸 🕒 пн, 7 мар. 2022 г., 19:20:00 MSK United States Medical Diagnostics Market Insights & Forecasts, 2022-2026 with Potential Impact of COVID-19 - ResearchAndMarkets.com The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to …May 17, 2023 · Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical Company focused on novel and targeted oncology anno
Stock Data · SEC Filings · Governance · Contact · Careers. Management Team. About. About ... (NASDAQ: BDSI), Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and ...The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to …
Apr 25, 2023 · In addition, Spectrum stockholders will get one CVR per Spectrum share entitling them to receive up to an additional $0.20 per share in total (~$43M), payable in cash or stock at Assertio's ... Price/Book 7.89 Trade SPPI with: Price/Earnings ttm 0.00 Earnings Per Share ttm -0.37 Most Recent Earnings -0.02 on 05/09/23 Next Earnings Date 08/10/23 Annual Dividend & Yield N/A (0.00%) Most Recent Dividend 0.150 on 12/18/12 Sectors: Options Overview Details View History Implied Volatility 0.00% ( unch) Historical Volatility 41.98% Mar 23, 2022 ... Spectrum Pharmaceuticals has resubmitted the BLA for eflapegrastim ... Image: Stock Photo Secrets. But during his firm's fourth quarter 2021 ...Specialty pharmaceutical company Assertio Holdings Inc announced Tuesday that it finalized an agreement to acquire all outstanding shares of Spectrum Pharmaceuticals Inc in an all-stock and ...Apr 25, 2023 · Under the terms of the agreement, at closing, Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock they own ... Spectrum shareholders will receive 1.1783 shares of Assertio stock for each share of Spectrum stock they own, the companies said. The deal is worth approximately $248 million.will acquire Spectrum Pharmaceuticals Inc SPPI in an all-stock and contingent value rights (CVR) transaction. Under the terms of the agreement, each Spectrum share will be exchanged for a...
Spectrum Pharmaceuticals (NASDAQ:SPPI), based in Boston, is an exception. SPPI stock was recently trading for 58 cents per share, a market cap of $118 million.
Dec 1, 2023 · Spectrum Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement SA News Wed, May 17 Spectrum Pharmaceuticals GAAP EPS of -$0.02 beats by $0.03, revenue of $15.6M beats by $1.44M
Autism spectrum disorder (ASD) is a condition that can make it difficult for your child to communicate with others. Because ASD is a spectrum, people will need different types of treatment.This EMPLOYEE STOCK PURCHASE PLAN (the “Plan”) is hereby established by Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”) as of March 23, 2009.The Plan was amended and restated as of September 21, 2018.Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224.419.7106 Fax: 510.744.8001 Managing your monthly bills can be a daunting task, especially when you have multiple payments to make. One bill that many people struggle with is their Spectrum bill. One of the biggest advantages of setting up auto pay for your Spectrum b...BOSTON, January 31, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology, today announced business highlights and preliminary ...🇺🇸 🕒 пн, 7 мар. 2022 г., 19:30:05 MSK Outlook on the Oral Cancer Treatment Global Market to 2030 - Increase in Number of Pipeline Drugs Presents Opportunities DUBLIN, March 7, 2022 /PRNewswire/ -- The "Oral Cancer Treatment Market: Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's …Transaction Expected to be Significantly Accretive to Assertio in 2024. LAKE FOREST, Ill., July 31, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq ...Spectrum Pharmaceuticals's stock symbol is SPPI What is Spectrum Pharmaceuticals's official website? Spectrum Pharmaceuticals's official website is www.sppirx.Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI) ... Spectrum stockholders will receive a fixed exchange ratio of 0.1783 shares of Assertio common stock for each share of Spectrum common stock ...Spectrum Pharmaceuticals (NASDAQ:SPPI) has a recorded net income of -$75.40 million. SPPI has generated -$0.36 earnings per share over the last four quarters.
4 analysts have issued 1-year target prices for Spectrum Pharmaceuticals' stock. Their SPPI share price targets range from $0.75 to $4.00. On average, they anticipate the company's share price to reach $2.92 in the next twelve months. This suggests a possible upside of 183.2% from the stock's current price.Apr 25, 2023 · Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 ASRT shares per SPPI Share ($1.14 per share) Plus One CVR for Total Potential Consideration of up to $1.34 per Share Upfront... The 52-week high for Spectrum Pharmaceuticals Stock is $1.36 and the 52-week low is $0.315. What is the market capitalization of Spectrum Pharmaceuticals Stock? As of the 2023-10-30, the market capitalization of Spectrum Pharmaceuticals is …Apr 25, 2023 · By noon, Spectrum stock had risen about 20% on the news, bringing each share to about 83 cents. The company has a market capitalization of $172.9 million, well above the $75.1 million cash it ... Instagram:https://instagram. trading scanneris fan duel legal in floridakenvue jandjnovo on 52nd The latest closing stock price for Spectrum Pharmaceuticals, Inc. on July 31, 2023 is 1.03. The all-time high Spectrum Pharmaceuticals, Inc. closing stock price was 598.32 on March 07, 2000. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. exp realty stockare dental discount plans better than insurance Sep 23, 2022 ... After an almost yearlong wait, Spectrum Pharmaceuticals has received ... Spectrum's stock dropped by 38% over the course of Tuesday, the day ...The 52-week high for Spectrum Pharmaceuticals Stock is $1.36 and the 52-week low is $0.315. What is the market capitalization of Spectrum Pharmaceuticals Stock? As of the 2023-10-30, the market capitalization of Spectrum Pharmaceuticals is … stock broker commission percentage Suven Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Duty Drawback and Export Incentives for the year ending 31-Mar-2022. For the quarter ended 30-09-2023, the company has reported a Consolidated Total Income of Rs 250.90 Crore, down 29.96 % from last quarter Total …It also withdrew its outlook for the full year of 2023! Assertio (NASDAQ: ASRT) stock is falling hard on Friday after the pharmaceutical company released its second-quarter earnings report ...BOSTON, January 31, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology, today announced business highlights and preliminary ...